Propanc Biopharma (PPCB) Share-based Compensation (2011 - 2026)
Propanc Biopharma (PPCB) reported Share-based Compensation of $2.91 million for fiscal Q4 2026 (quarter ended Jun 30, 2026).
Powered by 
Analysis
Propanc Biopharma (PPCB) Share-based Compensation (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Propanc Biopharma posted Share-based Compensation of $8.5 million, down 83.4% from FY2025.
- Share-based Compensation has a five-year compound annual growth rate of 132.3% (FY2021 to FY2026).
- By fiscal year, Share-based Compensation came in at $51.35 million in FY2025, $138,948 in FY2023 (-55.8%) and $314,626 in FY2022 (+150.6%).
- Five-year quarterly Share-based Compensation spans a low of $2,408 in fiscal Q1 2023 and a high of $51.33 million in fiscal Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Propanc Biopharma | 360,710.60 | -1.65 Mn | - | 8.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.49 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 51.33 Mn |
| Dec 31, 2024 | 7,500.00 |
| Sep 30, 2024 | 7,500.00 |
| Jun 30, 2023 | 82,137.00 |
| Dec 31, 2022 | 54,403.00 |
| Sep 30, 2022 | 2,408.00 |
| Jun 30, 2022 | 92,174.00 |
| Mar 31, 2022 | 20,718.00 |
| Dec 31, 2021 | 20,718.00 |
| Sep 30, 2021 | 133,422.00 |
| Jun 30, 2021 | 58,061.00 |
| Mar 31, 2021 | 20,718.00 |
| Dec 31, 2020 | 20,718.00 |
| Sep 30, 2020 | 20,718.00 |
| Jun 30, 2020 | 52,842.00 |
| Mar 31, 2020 | 20,718.00 |
| Dec 31, 2019 | 20,718.00 |
API Access
Propanc Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();